Groombridge, Wu, Baughman & Stone

Firm overview:

Groombridge, Wu, Baughman & Stone is a patent litigation firm that tries cases in court, in arbitrations and in the International Trade Commission, as well as arguing appeals before the Federal Circuit. Groombridge Wu has been active before the Patent Trial and Appeal Board (PTAB) since its inception in 2012, filing multiple petitions on its first morning of operation, and has appeared in more than 190 inter partes reviews, post-grant reviews, and covered business method reviews on behalf of both petitioners and patent owners.

In the decades before founding the firm, its partners have led representations for many innovative companies at the forefront of their industries, including 10x Genomics, Amgen, Google, Edwards Lifesciences, and Siemens.

Team overview:

Over 35 years, Nick Groombridge has been lead counsel in over 150 patent cases in federal district courts, has tried dozens of bench and jury trials, and has successfully argued more than 30 cases in the Court of Appeals for the Federal Circuit.

Groombridge has litigated patents across technical areas including software, semiconductors, pharmaceuticals, biotechnology and medical devices.

Key matters:

● IPR2024-00107 Sun Pharmaceutical Industries v Novo Nordisk.

Groombridge, Wu, Baughman & Stone, led by Steven Baughman, represented patent owner Novo Nordisk in this patent matter concerning dosing regimes for the treatment of type 2 diabetes and obesity. Sun Pharma filed a patent suit against Novo Nordisk’s filing of a patent covering the invention at the PTAB. The case was terminated on January 10, 2025.

● Mylan Pharmaceuticals v Novo Nordisk, Patent Trial and Appeal Board, No. IPR2023-00724.

A Groombridge Wu team represented Novo Nordisk in patent litigation related to its blockbuster weight-loss drugs Ozempic and Wegovy. In October 2024, Novo and Viatris’s Mylan Pharmaceuticals said in a joint filing at the PTAB that they had reached a settlement. Viatris had challenged Novo’s patents covering the drugs at the US Patent and Trademark Office.

Groombridge, Wu, Baughman & Stone advised Siemens in an ITC investigation involving LED technology.

Clients:

10X Genomics, Amgen, Aruba Networks, Biogen, Cabaret Biotech, Edwards Life Sciences, Garmin, Liberty Mutual Insurance Company, Motorola, Novo Nordisk, SAP, Siemens.